| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2005 | EP1355906B1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 01/12/2005 | EP1353918B1 Morpholine derivatives as antagonists of orexin receptors |
| 01/12/2005 | EP1331926B1 Fast-acting antimicrobial lotion with enhanced efficacy |
| 01/12/2005 | EP1324758B1 Plga/pla-type polymer microspheres encapsulating a water-soluble substance and process thereof |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1305314B1 Crystalline therapeutic agent |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/12/2005 | EP1286666B1 Starter kit for low dose oral contraceptives |
| 01/12/2005 | EP1284711B1 Process for making a blister package containing topiramate tablets |
| 01/12/2005 | EP1259502B1 Biologically active analogs of discodermolide |
| 01/12/2005 | EP1244359B1 Combination of fluazuron and ivermectin for parasite control |
| 01/12/2005 | EP1242053B1 Apparatus and method for preparing microparticles using in-line solvent extraction |
| 01/12/2005 | EP1231894B1 Pharmaceutical formulations of salmeterol |
| 01/12/2005 | EP1230209B1 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | EP1227797B1 Solid dispersion pharmaceutical formulations |
| 01/12/2005 | EP1227734B1 Compositions comprising edible oils or fats and phytosterols and/or phytostanols dissolved therein |
| 01/12/2005 | EP1226212A4 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 01/12/2005 | EP1194122B1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 01/12/2005 | EP1194044B1 Pharmaceutical or dietetic mushroom-based compositions and their use |
| 01/12/2005 | EP1189913B1 Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 01/12/2005 | EP1185241B1 Compositions containing avenanthramides from oat extract |
| 01/12/2005 | EP1183254B1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 01/12/2005 | EP1183228B1 Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds. |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | EP1165532B1 Antibacterial agents |
| 01/12/2005 | EP1150686B1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 01/12/2005 | EP1150680B1 Use of moxonidine for postmyocardial infarction treatment |
| 01/12/2005 | EP1117387B1 Coated medicament forms with controlled active substance release |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1098877A4 Derivatized polymers of alpha-olefin-maleic anhydride alkyl half-ester or full acid |
| 01/12/2005 | EP1089713B1 Temperature-sensitive liposomal formulation |
| 01/12/2005 | EP1087773B1 Vaginal active agent delivery procedures and formulations thereof |
| 01/12/2005 | EP1077711B1 Treatment of papilloma virus infection using a mycobacterium |
| 01/12/2005 | EP1063987A4 Dietary control of arachidonic acid metabolism |
| 01/12/2005 | EP1036083B9 Novel 9a-azalides |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | EP1019026B1 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 01/12/2005 | EP1005333B1 Methods and compositions for preventing and treating chronological aging in human skin |
| 01/12/2005 | EP1002082B1 Transcriptional silencer protein nrf |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | EP0988860B1 Use of a-glycosylceramides for the manufacture of a therapeutic agent for autoimmune diseases |
| 01/12/2005 | EP0973498B1 Gastrointestinal mucosa-adherent pharmaceutical composition |
| 01/12/2005 | EP0958823B1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | EP0893442B1 Lymph-absorbable imidazole derivatives |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0749304B9 Slow-release tablet containing diclofenac-na |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564822A Antitumoral analogs |
| 01/12/2005 | CN1564821A 5-methoxy-8-aryl-[1, 2, 4]triazolo[1, 5-a]pyridine derivatives as adenosine receptor antagonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564817A Novel benzothiazine derivatives, their preparation and use |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564809A Organic compounds |
| 01/12/2005 | CN1564806A Processes for the production of alpha-difluoromethyl ornithine (DFMO) |
| 01/12/2005 | CN1564796A Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564695A Pharmaceutical formulation |
| 01/12/2005 | CN1564691A Interval drug release system of convulsion relieving agent |
| 01/12/2005 | CN1564690A Tetracycline derivatives and methods of use thereof |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1564688A Methods of treating pulmonary disease |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1564686A 8-amino- [1, 2, 4]triazolo [1, 5-a]pyridine-6-carboxylic acid amide |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564684A Pharmaceutical compositions |
| 01/12/2005 | CN1564683A Methods for treating dry eye by a combination of an antiinflammatory steroid and a MUC-1 secretagogue |
| 01/12/2005 | CN1564682A Compositions for potentiating glutatthione |
| 01/12/2005 | CN1564681A Treatment of nail infections using NO generating compositions |
| 01/12/2005 | CN1564679A Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1564676A Invert emulsion containing DHEA |
| 01/12/2005 | CN1563571A Paper to wtel for brushing teeth |
| 01/12/2005 | CN1563104A Method for extracting and purifying polysaccharide from aconite root of Chinese traditional medicine |
| 01/12/2005 | CN1563074A Compound of steroid saponin class, preparation method and combination of medication containing compound |
| 01/12/2005 | CN1563069A 6 gene of neurenergen sourced from human, and application |
| 01/12/2005 | CN1563028A Flavonoid extract product containing pedaliin and application |
| 01/12/2005 | CN1563026A Glycoside class compound of phenethyl alcohol alcohol extracted from picria fel-terrae |
| 01/12/2005 | CN1563025A Segment of oligosaccharide alginic acd, preparation method and application |
| 01/12/2005 | CN1563023A 3, 6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and accessory ingredient of transition metal, preparation and application |
| 01/12/2005 | CN1563014A New compound ramification of garcinia acid |
| 01/12/2005 | CN1563011A Compounds of podophyllotoxins, application and preparation method |
| 01/12/2005 | CN1563010A Method for preparing inophyllolide C2 and application of preparing medication of anti SARS |
| 01/12/2005 | CN1563007A 9-(2-fatty ester ethoxy methyl) guanine, liposome, and preparation emthod |
| 01/12/2005 | CN1563004A Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 01/12/2005 | CN1562996A Extract products of exopleura of sorghum, extracting method and application |
| 01/12/2005 | CN1562994A Producing technique for extracting extract products of amentoflavone |
| 01/12/2005 | CN1562992A Technique for extracting general coumarin and monomer components from cnidium fruit and medicinal preparation |
| 01/12/2005 | CN1562978A Compound of multiple substituted uracil class, preparation method and usage |
| 01/12/2005 | CN1562973A New method for preparing Aripiprazole |
| 01/12/2005 | CN1562972A Medicinal compound for curing disease of gastrointestinal tract, preparation method and relevant medication |
| 01/12/2005 | CN1562970A PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 01/12/2005 | CN1562930A Preparation of ramification of polyhalo-substitution diphenyl ethers and medication application |
| 01/12/2005 | CN1562373A Method for preparing solid dosage forms type microsphere of alcohol soluble protein from source of plants |
| 01/12/2005 | CN1562370A Antiphlogistic and antirheumatic compound preparation |
| 01/12/2005 | CN1562369A Combination of medication for curing high blood pressure |